Highlights•Triple therapy in a single inhaler is a new therapeutic option for COPD.•Three
fixed dose combinations of inhaled corticosteroids LABA and LAMA are in Phase III of …

Corticosteroids are widely used in the treatment of chronic obstructive pulmonary disease
(COPD). However, in contrast to their use in mild-to-moderate asthma, they are much less …

We investigated the incidence of type II diabetes mellitus (T2DM) among people with COPD
and whether exposure to inhaled corticosteroid (ICS) and exacerbation status was …

The aim of this proof-of-concept, pilot study was the evaluation of the effects of steroid
administration and suspension of an inhaled corticosteroid (ICS)-long-acting β2-agonist …

Background: Macrolide antibiotics have anti-inflammatory effects, and long-term
administration may reduce chronic obstructive pulmonary disease (COPD) exacerbations …

Inhaled corticosteroid (ICS) therapy is widely prescribed without a history of exacerbations
and consensus guidelines suggest withdrawal of ICS in these patients would reduce the risk …

Combinations of two long-acting bronchodilators and long-acting bronchodilators with
inhaled corticosteroids (ICS) are recommended therapies in the management of chronic …

Introduction: Respiratory infections and diseases are accompanied by or exhibit
inflammation. Recent advances in nanoparticle engineering technology, together with the …

Inhaled corticosteroids (ICS) have been used as first line treatment of asthma for many
decades. ICS are a form of exogenous glucocorticosteroids that can suppress the …

慢性阻塞性肺疾病(COPD) 作为一个发病率越来越高的健康杀手, 其发病机制被认为与肺脏因
吸入有害气体或颗粒而引起的异常炎症反应有关. 用于治疗COPD 的药物包括支气管扩张剂和抗 …